DrugDashboards

Market view

bupivacaine hydrochloride in dextrose

3 marketed package NDCs · 1 active manufacturer

The short version

Only one company currently supplies this market — there is no backup if it stumbles. It is in shortage right now — FDA lists the reason as “other”.

Same drug class

Other molecules FDA puts in Amide Local Anesthetic, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Bupivacaine hydrochloride in dextrose in shortage right now?
Yes. FDA currently lists Bupivacaine hydrochloride in dextrose in shortage, with the reason given as "other". This page is rebuilt every morning from FDA's shortage database.
Who makes Bupivacaine hydrochloride in dextrose?
1 company has marketed Bupivacaine hydrochloride in dextrose in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

Shortage reports for this molecule

  • In shortage now — Bupivacaine Hydrochloride, Injection, Bupivacaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose) (NDC 0409-3613-01)Feb 20, 2018
  • In shortage now — Marcaine, Injection, 0.75% 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25% (NDC 0409-1761-10)Feb 20, 2018
  • In shortage now — Marcaine, Injection, 0.75% 15 mg/2 mL (NDC 0409-1761-62)Feb 20, 2018

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.